SCHEMBL20174713

SCHEMBL20174713

c1ccc2c(c1)-c1ccc(-c3nc(-c4ccc5ccccc5c4)nc(-c4ccc5ccccc5c4)n3)cc1C21c2ccccc2-c2oc3ccccc3c21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.33
CYP1A2 P05177 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
PRKDC P78527 1/20 0.31
ALDH1A1 P00352 3/20 0.31
MAPT P10636 2/20 0.31
MAOB P27338 1/20 0.30
ALOX5 P09917 1/20 0.30
KMT2A Q03164 2/20 0.30
KDM4E B2RXH2 2/20 0.30
TP53 P04637 2/20 0.30
HSD17B10 Q99714 2/20 0.30
MEN1 O00255 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
MAPK1 P28482 1/20 0.30
NPC1 O15118 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174277 0.96 PIM1 (0.36) PIM1CYP1A2SMN1; SMN2SLC6A2SLC6A4
SCHEMBL20174293 0.94 PIM1 (0.30) PIM1SLC6A2SLC6A4SLC6A3
SCHEMBL20174249 0.93 ALDH1A1 (0.33) PIM1CYP1A2SMN1; SMN2ALDH1A1MAPT
SCHEMBL20174255 0.92 CYP1A1 (0.38) PIM1CYP1A2SMN1; SMN2ALDH1A1MAPT
SCHEMBL20174200 0.91 MAPT (0.34) SMN1; SMN2ALDH1A1MAPTALOX5KMT2A
SCHEMBL18590018 0.90 L3MBTL1 (0.34) PIM1CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL20174211 0.90 PDK2 (0.34) SMN1; SMN2ALDH1A1MAPTALOX5KMT2A
SCHEMBL20174261 0.89 CYP1A1 (0.39) PIM1CYP1A2SMN1; SMN2ALDH1A1MAPT
SCHEMBL18590038 0.89 SLC6A2 (0.33) PIM1SLC6A2SLC6A4SLC6A3PRKDC
SCHEMBL22326557 0.88 PDK2 (0.36) SMN1; SMN2ALDH1A1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG PIM1 2804/4885CYP1A2 436/4885SMN1; SMN2 3407/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG PIM1 2804/4885CYP1A2 436/4885SMN1; SMN2 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.